US equities |
SPCX $174.62 ▲+2.06% NVDA $242.32 ▲+1.43% MU $1,067.81 ▲+0.36% AMD $657.90 ▲+4.14% MRVL $292.00 ▲+7.65% SNDK $1,679.34 ▼-1.46% AVGO $377.40 ▲+4.11% TSLA $380.76 ▲+0.54%
FinancialContent

Cytek Biosciences, Inc. - Common Stock (NQ:CTKB)

5.625 -0.465 (-7.64%)
Delayed Quote Updated: 11:08 AM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytek Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
3 Stocks Insiders Are Buying ↗
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go... 
Via Benzinga
News headline image
The IPO Recap – Party Is Everything But Over ↗
Last week's 19 IPO week had a lot of life sciences and software. This week, US IPO activity continues at a record with 25 scheduled IPOs, marking the fifth week in 2021 with... 
Via Benzinga
Topics Initial Public Offering
News headline image
Cell Analysis Instruments Provider Cytek Biosciences Kick Starts Trading After Pricing IPO At $17 ↗
Cytek Biosciences Inc (NASDAQ: CTKB) shares started trading today after its initial public offering was priced to raise about $200 million for the cell-analysis Company.... 
Via Benzinga
Topics Initial Public Offering
News headline image
The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >